drugset / Trial / NCT06261489
Cannabis (THC vs. CBD) in Multiple Sclerosis
Phase 2
Active not recruiting
30 enrolled
University of Calgary
Multiple Sclerosis Society of Canada · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this clinical trial is to examine the effect of Cannabis components, THC and CBD, on cognition and bladder symptoms in people with Multiple Sclerosis (MS). Participants will complete questionnaires and cognitive tests. They will be randomly assigned to receive either CBD or THC oil and will take the study drug for 15 weeks.
Timeline
- Start
- 2025-12-05
- Primary completion
- 2026-09
- Completion
- 2026-09